AQR Capital Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.8M | Sell |
152,029
-14,311
| -9% | -$452K | ﹤0.01% | 1309 |
|
|
2025
Q1 | $5.52M | Buy |
166,340
+7,484
| +5% | +$248K | 0.01% | 1087 |
|
|
2024
Q4 | $5.47M | Buy |
158,856
+16,271
| +11% | +$560K | 0.01% | 1060 |
|
|
2024
Q3 | $5.7M | Sell |
142,585
-11,760
| -8% | -$470K | 0.01% | 993 |
|
|
2024
Q2 | $4.66M | Buy |
154,345
+1,116
| +0.7% | +$33.7K | 0.01% | 1054 |
|
|
2024
Q1 | $5.15M | Sell |
153,229
-26,526
| -15% | -$891K | 0.01% | 974 |
|
|
2023
Q4 | $5.81M | Buy |
179,755
+11,236
| +7% | +$363K | 0.01% | 886 |
|
|
2023
Q3 | $5.52M | Buy |
168,519
+22,126
| +15% | +$725K | 0.01% | 876 |
|
|
2023
Q2 | $5.15M | Buy |
146,393
+92,843
| +173% | +$3.27M | 0.01% | 889 |
|
|
2023
Q1 | $1.75M | Buy |
53,550
+21,627
| +68% | +$706K | ﹤0.01% | 1311 |
|
|
2022
Q4 | $1.76M | Sell |
31,923
-1,453
| -4% | -$80.1K | ﹤0.01% | 1311 |
|
|
2022
Q3 | $1.48M | Buy |
33,376
+22,653
| +211% | +$1M | ﹤0.01% | 1337 |
|
|
2022
Q2 | $523K | Buy |
+10,723
| New | +$523K | ﹤0.01% | 1669 |
|